Palisade Bio Inc expected to post a loss of $4.80 a share - Earnings Preview

Palisade Bio

08/05/2024 14:16

* Palisade Bio Inc  PALI.OQ   PALI.O  is expected to show a
fall
in quarterly revenue when it reports  results on May 10
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Palisade Bio Inc is for
a loss
of $4.80 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $33.75​, above​ its last closing price of $7.90. ​​​

This summary was machine generated May 8 at 13:16 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)